https://www.bqprime.com/business/laurus-labs-q4-results-review-brokerages-cut-estimates-on-uncertain-fy24-outlook
The drugmaker's net profit was down 55% year-on-year to Rs 103 crore in the quarter ended March, as per an exchange filing.
Create an account or login to join the discussion